Dr. Reddy's Laboratories Ltd ADR (RDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 236,000 | 186,000 | 182,000 | 77,000 | 259,000 |
| Depreciation Amortization | 175,000 | 132,000 | 87,000 | 42,000 | 165,000 |
| Income taxes - deferred | 125,000 | 91,000 | 54,000 | 40,000 | -19,000 |
| Accounts receivable | 28,000 | -22,000 | 22,000 | 48,000 | -165,000 |
| Accounts payable and accrued liabilities | 39,000 | 56,000 | 65,000 | 32,000 | 21,000 |
| Other Working Capital | -113,000 | -139,000 | -43,000 | -7,000 | -100,000 |
| Other Operating Activity | -2,000 | 31,000 | -93,000 | -88,000 | 235,000 |
| Operating Cash Flow | $488,000 | $335,000 | $274,000 | $144,000 | $396,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -132,000 | -93,000 | -54,000 | -20,000 | -62,000 |
| Net Acquisitions | -212,000 | -212,000 | -211,000 | -198,000 | N/A |
| Purchase Of Investment | -1,031,000 | -806,000 | -693,000 | -450,000 | -1,485,000 |
| Sale Of Investment | 1,087,000 | 951,000 | 725,000 | 459,000 | 1,482,000 |
| Purchase Sale Intangibles | -39,000 | -34,000 | -8,000 | -5,000 | -14,000 |
| Other Investing Activity | -22,000 | -21,000 | 2,000 | 1,000 | 0 |
| Investing Cash Flow | $-310,000 | $-181,000 | $-231,000 | $-208,000 | $-65,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 93,000 | N/A | 50,000 | 74,000 | N/A |
| Debt Issued | 52,000 | 52,000 | 52,000 | 25,000 | N/A |
| Debt Repayment | -51,000 | -51,000 | -51,000 | -25,000 | -304,000 |
| Common Stock Issued | 4,000 | 3,000 | 2,000 | 1,000 | N/A |
| Common Stock Repurchased | -16,000 | -3,000 | -3,000 | N/A | -6,000 |
| Dividend Paid | -57,000 | -57,000 | -56,000 | N/A | -52,000 |
| Other Financing Activity | -29,000 | -66,000 | -13,000 | 20,000 | 28,000 |
| Financing Cash Flow | $-4,000 | $-122,000 | $-19,000 | $95,000 | $-334,000 |
| Exchange Rate Effect | 2,000 | 1,000 | 0 | 1,000 | N/A |
| Beginning Cash Position | 27,000 | 27,000 | 27,000 | 26,000 | 30,000 |
| End Cash Position | 203,000 | 59,000 | 52,000 | 58,000 | 26,000 |
| Net Cash Flow | $176,000 | $32,000 | $25,000 | $32,000 | $-3,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 488,000 | 335,000 | 274,000 | 144,000 | 396,000 |
| Capital Expenditure | -133,000 | -94,000 | -54,000 | -20,000 | -64,000 |
| Free Cash Flow | 355,000 | 241,000 | 220,000 | 124,000 | 332,000 |